The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Bioactive Benzofuran derivatives: A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs
Winter, C. A., Risley, E. A., & Nuss, G. W. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-111-27849 · Cited by 5,688
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
D'AMOUR, F. E., & SMITH, D. L. (1941) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03823-6 · Cited by 3,231
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E.-W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,644
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 1,996
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
The Chemistry of the quinonoid compounds
Patai, S. (1974) · UMI Books on Demand · Cited by 1,320
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e318282ab8f · Cited by 1,294
A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives
McGrath, N. A., Brichacek, M., & Njardarson, J. T. (2010) · Journal of Chemical Education · doi:10.1021/ed1003806 · Cited by 1,188
Gordon, E. M., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gallop, M. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00036a001 · Cited by 1,142
Angiogenesis and Tumor Metastasis
Zetter, B. R. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.407 · Cited by 1,015
Pharmacology of drugs that alter multidrug resistance in cancer.
Ford, J. M., & Hait, W. N. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00045-6 · Cited by 974
Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein Precursor
Cai, X.-D., Golde, T. E., & Younkin, S. G. (1993) · Science · doi:10.1126/science.8424174 · Cited by 913
PROTEIN ISOPRENYLATION AND METHYLATION AT CARBOXYL-TERMINAL CYSTEINE RESIDUES
Clarke, S. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.002035 · Cited by 891
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Tamoxifen: a most unlikely pioneering medicine
Jordan, V. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1031 · Cited by 824
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Chun, J., & Hartung, H.-P. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cbf825 · Cited by 796
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622 · cited 1×
“A major hallmark of AD is the formation and accumulation of fibrillar β-amyloid (Aβ) peptides in the brain [119,120].”
BackgroundMechanism for irreversible self-deactivation of prostaglandin synthetase.
Egan, R. W., Paxton, J., & Kuehl, F. A. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32853-3 · Cited by 586
Privileged Structures: Applications in Drug Discovery
DeSimone, R., Currie, K., Mitchell, S., Darrow, J., & Pippin, D. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328544 · Cited by 577
The role of estrogen in the initiation of breast cancer
Russo, J., & Russo, I. H. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.004 · Cited by 575
Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics
Hammarström, P., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2003) · Science · doi:10.1126/science.1079589 · Cited by 525
For better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2986 · Cited by 481
PET imaging of amyloid in Alzheimer's disease
Nordberg, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 464
Clinical features of Alzheimer's disease
Förstl, H., & Kurz, A. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050101 · Cited by 442
Nathan, C. (2004) · Nature · doi:10.1038/431899a · Cited by 410
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Coezy, E. D., Borgna, J., & Rochefort, H. (1982) · PubMed · Cited by 394
The role of cerebral amyloid β accumulation in common forms of Alzheimer disease
Gandy, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25100 · Cited by 385
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., & Harrison, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1222 · Cited by 378
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
Reitz, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/369808 · Cited by 376
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
Understanding microtubule dynamics for improved cancer therapy
Honore, S., Pasquier, E., & Braguer, D. (2005) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5330-x · Cited by 319
Salomone, S., Caraci, F., Leggio, G. M., Fedotova, J., & Drago, F. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04134.x · Cited by 309
The New Era in Cancer Research
Varmus, H. (2006) · Science · doi:10.1126/science.1126758 · Cited by 308
Jordan, V. C., & Brodie, A. M. H. (2007) · Steroids · doi:10.1016/j.steroids.2006.10.009 · Cited by 296
Jan, A., Gokce, O., Luthi-Carter, R., & Lashuel, H. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803159200 · Cited by 291
Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence
Diamant, M., & Heine, R. J. (2003) · Drugs · doi:10.2165/00003495-200363130-00004 · Cited by 277
GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesity
Overton, H. A., Fyfe, M. C. T., & Reynet, C. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707529 · Cited by 264
International Union of Pharmacology nomenclature of endothelin receptors.
Masaki, T., Vane, J. R., & Vanhoutte, P. M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06781-x · Cited by 256
The cause of neuronal degeneration in Alzheimer’s disease
Vickers, J. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00023-4 · Cited by 254
Imaging β-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain
Mathis, C., Wang, Y., & Klunk, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384772 · Cited by 243
Ras Farnesyltransferase: A New Therapeutic Target
Leonard, D. M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970226l · Cited by 241
Amson, R., Sigaux, F., Przedborski, S., Flandrin, G., Givol, D., & Telerman, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8857 · Cited by 231
Kataoka, H., Sugahara, K., Shimano, K., Teshima, K., Koyama, M., Fukunari, A., & Chiba, K. (2005) · PubMed · Cited by 216
A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity
Wolfe, M. S., Citron, M., Diehl, T. S., Xia, W., Donkor, I. O., & Selkoe, D. J. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970621b · Cited by 215
Novel Stilbenes as Probes for Amyloid Plaques
Kung, H. F., Lee, C.-W., Zhuang, Z.-P., Kung, M.-P., Hou, C., & Plössl, K. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0167147 · Cited by 180
Hassan, G. S., Abou‐Seri, S. M., Kamel, G. M., & Ali, M. M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.033 · Cited by 169
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci
Leclercq, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02739.x · Cited by 160
Chiba, K., Matsuyuki, H., Maeda, Y., & Sugahara, K. (2006) · PubMed · Cited by 158
Pasquier, E., André, N., & Braguer, D. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662266 · Cited by 149
Semple, G., Fioravanti, B., Pereira, G. R., Calderon, I., Uy, J., Choi, K., Xiong, Y., Ren, A., Morgan, M. E., Davé, V., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006867 · Cited by 144
Antipyretic testing of aspirin in rats*1
Loux, J. J. (1972) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(72)90295-5 · Cited by 144
Léon, C., Freund, M., Ravanat, C., Baurand, A., Cazenave, J., & Gachet, C. (2001) · Circulation · doi:10.1161/01.cir.103.5.718 · Cited by 139
Gaisina, I. N., Gallier, F., Ougolkov, A. V., Kim, K. H., Kurome, T., Guo, S., Holzle, D. L., Luchini, D. N., Blond, S. Y., Billadeau, D. D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801317h · Cited by 132
Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria
Spaniol, M. M., Bracher, R., Ha, H. R., Folláth, F., & Krähenbühl, S. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00189-1 · Cited by 131
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics
Lee, M. D., She, Y., Soskis, M. J., Borella, C. P., Gardner, J. R., Hayes, P. A., Dy, B. M., Heaney, M. L., Philips, M. R., Bornmann, W. G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422269 · Cited by 123
Docking Study Yields Four Novel Inhibitors of the Protooncogene Pim-1 Kinase
Pierce, A. C., Jacobs, M. D., & Moody, C. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701248t · Cited by 121
Cohen, A., Grinblat, B., Bessler, H., Kristt, D., Kremer, A., Shalom, S., Schwartz, A., Halperin, M., Merkel, D., & Don, J. (2004) · Leukemia and Lymphoma · doi:10.1080/10428190310001641251 · Cited by 119
Why Target PIM1 for Cancer Diagnosis and Treatment?
Magnuson, N. S., Wang, Z., Ding, G., & Reeves, R. (2010) · Future Oncology · doi:10.2217/fon.10.106 · Cited by 119
New Ruthenium(II)–Letrozole Complexes as Anticancer Therapeutics
Castonguay, A., Doucet, C., Juhas, M., & Maysinger, D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301103y · Cited by 118
Katz, L., Gambale, J. J., Rothenberg, P., Vanapalli, S. R., Vaccaro, N. M., Xi, L., Sarich, T. C., & Stein, P. P. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01587.x · Cited by 114
Novel Benzofuran Derivatives for PET Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains
Ono, M., Kawashima, H., Nonaka, A., Kawai, T., Haratake, M., Mori, H., Kung, M., Kung, H. F., Saji, H., & Nakayama, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051176k · Cited by 107
Tsunoda, K., Abe, K., Hagino, T., Omata, K., Misawa, S., Imai, Y., & YOSHINAGA, K. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.1.28 · Cited by 106
The therapeutic potential of GPR119 agonists for type 2 diabetes
Ohishi, T., & Yoshida, S. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.657797 · Cited by 99
Pagels, W. R., Sachs, R. J., Marnett, L. J., DeWitt, D. L., Day, J. S., & Smith, W. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32442-6 · Cited by 97
Boyer, J. L., Adams, M., Ravi, R. G., Jacobson, K. A., & Harden, T. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704673 · Cited by 94
Selkoe, D. J. (2000) · Nature Biotechnology · doi:10.1038/78422 · Cited by 94
Baumruker, T., Billich, A., & Brinkmann, V. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.3.283 · Cited by 94
Lan, H., Lin, H. V., Cf, W., Wright, M. J., Xu, S. S., Kang, L., Juhl, K., Hedrick, J., & Kowalski, T. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01754.x · Cited by 93
Clopidogrel: A Review of its Use in the Prevention of Thrombosis
Plosker, G. L., & Lyseng-Williamson, K. A. (2007) · Drugs · doi:10.2165/00003495-200767040-00013 · Cited by 87
Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro
Hur, J.-M., Shim, J. S., Jung, H. J., & Kwon, H. J. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.18 · Cited by 87
Tao, Z., Hasvold, L. A., Leverson, J. D., Han, E. K.-H., Guan, R., Johnson, E. F., Stoll, V. S., Stewart, K. D., Stamper, G. F., Soni, N. B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900943h · Cited by 85
Yadav, P., Singh, P., & Tewari, A. K. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.087 · Cited by 83
Guardamagna, O., Abello, F., Saracco, P., Baracco, V., Rolfo, E., & Pirro, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.006 · Cited by 80
Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease
Huang, L., Miao, H., Sun, Y., Meng, F., & Li, X. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.081 · Cited by 80
Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease
Kellerman, D., Evans, R., Mathews, D., & Shaffer, C. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00154-0 · Cited by 79
The ras/cholesterol connection: implications for ras oncogenicity.
Cox, A. D., & Der, C. J. (1992) · PubMed · Cited by 77
Romagnoli, R., Baraldi, P. G., Carriòn, M. D., Lopez-Cara, L. C., Cruz‐López, O., Tolomeo, M., Grimaudo, S., Cristina, A. D., Pipitone, R. M., Balzarini, J. M., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.027 · Cited by 76
Cheng, Y., Ono, M., Kimura, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201513c · Cited by 72
Farnesylated proteins and cell cycle progression
Tamanoi, F., Kato‐Stankiewicz, J., Chen, J., Machado, I. M. P., & Thapar, N. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10067 · Cited by 65
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors
Xiang, Y., Hirth, B. H., Asmussen, G., Biemann, H.-P., Bishop, K. A., Good, A. C., Fitzgerald, M., Gladysheva, T. B., Jain, A., Jancsics, K., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.030 · Cited by 65
Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
Welker, M. E., & Kulik, G. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.083 · Cited by 63
Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation
Byun, J. H., Kim, H., Kim, Y. S., Mook‐Jung, I., Kim, D. J., Lee, W. K., & Yoo, K. H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.111 · Cited by 62
Malpani, Y. R., Achary, R., Kim, S. Y., Jeong, H. C., Kim, P., Han, S. B., Kim, M., Lee, C.-K., Kim, J. N., & Jung, Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.015 · Cited by 59
Synthesis and antifungal activity of benzofuran-5-ols
Ryu, C., Song, A. L., Lee, J. Y., Hong, J. A., Yoon, J. H., & Kim, A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.129 · Cited by 57
Hranjec, M., Sović, I., Ratkaj, I., Pavlović, G., Ilić, N., Valjalo, L., Pavelić, K., Pavelić, S. K., & Karminski-Zamola, G. M. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.11.009 · Cited by 55
Sashidhara, K. V., Modukuri, R. K., Sonkar, R., Rao, K. B., & Bhatia, G. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.009 · Cited by 52
Radiolabeled bioactive benzoheterocycles for imaging β-amyloid plaques in Alzheimer's disease
Yang, Y., & Cui, M. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.012 · Cited by 49
Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein
Fuse, S., Matsumura, K., Fujita, Y., Sugimoto, H., & Takahashi, T. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.095 · Cited by 48
Nguyễn, P. H., Nguyen, A. T. N., Đào, T. T., Kang, H.-W., Ndinteh, D.-T., Mbafor, J. T., & Oh, W. K. (2010) · Journal of Natural Products · doi:10.1021/np900745g · Cited by 48
Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors
Dixit, M., Tripathi, B. K., Tamrakar, A. K., Srivastava, A. K., Kumar, B. N., & Goel, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.053 · Cited by 47
Katz, L., Gambale, J. J., Rothenberg, P., Vanapalli, S. R., Vaccaro, N. M., Xi, L., Polidori, D., Vets, E., Sarich, T. C., & Stein, P. P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.169 · Cited by 47
Verzijl, D., Peters, S. L. M., & Alewijnse, A. E. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0041-z · Cited by 45
Role of protein tyrosine phosphatase-1B in diabetes and obesity
Kennedy, B. P. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)88105-6 · Cited by 43
Differential Effects of Oral Hypoglycemic Agents on Glucose Control and Cardiovascular Risk
Uwaifo, G. I., & Ratner, R. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.006 · Cited by 43
Wyatt, P. G., Allen, M. J., Chilcott, J., Gardner, C. J., Livermore, D. G., Mordaunt, J. E., Nerozzi, F., Patel, M., Perren, M. J., Weingarten, G. G., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00160-9 · Cited by 42
Chapter 7 The Emergence of GPR119 Agonists as Anti-Diabetic Agents
Jones, R. M., & Leonard, J. N. (2009) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(09)04407-8 · Cited by 41
Synthesis and structure–activity relationships of novel benzofuran farnesyltransferase inhibitors
Asoh, K., Kohchi, M., Hyoudoh, I., Ohtsuka, T., Masubuchi, M., Kawasaki, K., Ebiike, H., Shiratori, Y., Fukami, T. A., Kondoh, O., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.074 · Cited by 41
Benzofuran derivatives as anticancer inhibitors of mTOR signaling
Salomé, C., Ribeiro, N., Chavagnan, T., Thuaud, F., Serova, M., Gramont, A. D. E., Faivre, S. J., Raymond, É., & Désaubry, L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.014 · Cited by 40
Jiang, N., Li, S., Xie, S., Li, Z., Wang, K. D. G., Wang, X., & Kong, L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.004 · Cited by 39
Saha, A. K., Xiang, Y., Lin, J., Lobera, M., Sharadendu, A., Chereku, S., Schutz, N. C., Segal, D., Marantz, Y., McCauley, D., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100227q · Cited by 38
Kaffy, J., Brinet, D., Soulier, J. L., Khemtémourian, L., Lequin, O., Taverna, M., Crousse, B., & Ongeri, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.031 · Cited by 37
Hearn, B. R., Shaw, S. J., & Myles, D. C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00205-4 · Cited by 36
Cheng, Y., Ono, M., Kimura, H., Kagawa, S., Nishii, R., & Saji, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.016 · Cited by 35
Airoldi, C., Mourtas, S., Cardona, F., Zona, C., Sironi, E., D’Orazio, G., Markoutsa, E., Nicotra, F., Antimisiaris, S. G., & Ferla, B. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.085 · Cited by 31
Mehdi, S. H., Hashim, R., Ghalib, R. M., da Silva, M. F. C. G., Sulaiman, O., Rahman, S. Z., Murugaiyah, V., & Marimuthu, M. M. (2011) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2011.09.026 · Cited by 27
Ram, V. J. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8012-1_3 · Cited by 23
Al‐Qirim, T. M., Shattat, G. F., Sweidan, K., El‐Huneidi, W., Sheikha, G. M. A., Khalaf, R. A., & Hikmat, S. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201100225 · Cited by 22
Emerging antidyslipidemic drugs
Pollex, R. L., JOY, T. R., & Hegele, R. A. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.363 · Cited by 19
Saito, M., Ueo, M., Kametaka, S., Saigo, O., Uchida, S., Hosaka, H., Sakamoto, K., Nakahara, T., Mori, A., & Ishii, K. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1959 · Cited by 17
Skalska, A., & Grodzicki, T. K. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.97 · Cited by 13
Restoring functions of tumor suppressors with small molecules
Smukste, I., & Stockwell, B. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00307-6 · Cited by 12
Yuan, S., Dai, D., Guan, L., Dai, Y., & Ji, M. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04488.x · Cited by 8
Cited by
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview
Bozorov, K., Zhao, J., & Aisa, H. A. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.07.005 · Cited by 854
Martins, P., Jesus, J., Santos, S., Raposo, L., Roma-Rodrigues, C., Baptista, P., & Fernandes, A. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 716
Natural source, bioactivity and synthesis of benzofuran derivatives
Miao, Y.-H., Hu, Y.-H., Yang, J., Liu, T., Sun, J., & Wang, X.-J. (2019) · RSC Advances · doi:10.1039/c9ra04917g · Cited by 354
Calling from distance: attraction of soil bacteria by plant root volatiles
Schulz-Bohm, K., Gerards, S., Hundscheid, M., Melenhorst, J., de Boer, W., & Garbeva, P. (2018) · The ISME Journal · doi:10.1038/s41396-017-0035-3 · Cited by 316
Construction of Nine‐Membered Heterocycles through Palladium‐Catalyzed Formal [5+4] Cycloaddition
Yang, L., Rong, Z., Wang, Y., Tan, Z. Y., Wang, M., & Zhao, Y. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611474 · Cited by 295
Metadata
- Authors
- Khanam, H., & Shamsuzzaman
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 97
- Pages
- 483-504
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1967278636
- Cited by
- 554
- References
- 126
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.